Has Thu Ngo received payments from drug or device companies?

Yes. Drug and device makers reported $12,077 in general payments to Thu Ngo across 580 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Thu Ngo did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Thu Ngo come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Thu Ngo

Psychiatric/Mental Health · Lewisville, TXNPI 1730456898

Payments from drug & device makers

$12,077in general payments, 2019–2025

Across 580 payments — averaging $20.82 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$2K
Johnson & Johnson$1K
Neurocrine Biosciences, Inc.$965
AbbVie$963
Otsuka America Pharmaceutical, Inc.$813
Teva Pharmaceuticals USA, Inc.$795
plus $6K from 21 others

What the payments were for

Food & beverage$11,98199%
Education$961%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)	74	$1,600
Johnson & Johnson	60	$1,111
Neurocrine Biosciences, Inc.	35	$965
AbbVie	75	$963
Otsuka America Pharmaceutical, Inc.	40	$813
Teva Pharmaceuticals USA, Inc.	38	$795
Corium, LLC	30	$783
Validus Pharmaceuticals LLC	8	$703
Alkermes, Inc.	28	$697
Lundbeck LLC	51	$654
Tris Pharma Inc	12	$637
Takeda Pharmaceuticals U.S.A., Inc.	33	$628
E.r. Squibb & Sons, L.L.C.	18	$388
Axsome Therapeutics, Inc.	19	$361
Ironshore Pharmaceuticals Inc.	23	$335
Noven Therapeutics, LLC	9	$147
Vanda Pharmaceuticals Inc.	7	$143
Idorsia Pharmaceuticals US Inc	5	$98
Neos Therapeutics, LP	4	$68
Sunovion Pharmaceuticals Inc.	2	$35
Merck	2	$32
Supernus Pharmaceuticals, Inc.	2	$30
Orexo US, Inc.	1	$22
Sage Therapeutics, LLC	1	$20
Almatica Pharma LLC	1	$17
Bausch Health US, LLC	1	$17
Eisai Inc.	1	$14

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$12,077 in reported general payments places this provider in the 95th percentile of 2,724 psychiatric/mental health providers in Texas.

See all psychiatric/mental health providers in Texas →

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
AustedoDeutetrabenazine	12	$72,731
RexultiBrexpiprazole	16	$38,959
CaplytaLumateperone Tosylate	11	$17,014
Desvenlafaxine Succinate ErDesvenlafaxine Succinate	17	$1,490
Bupropion XlBupropion Hcl	40	$1,239
Lamotrigine	34	$973
Venlafaxine Hcl ErVenlafaxine Hcl	24	$888
Buspirone Hcl	18	$431
Alprazolam	67	$402
Clonazepam	37	$390
Trazodone Hcl	34	$319
Zolpidem Tartrate	43	$295
Fluoxetine Hcl	18	$284
Lithium Carbonate ErLithium Carbonate	17	$222
Lithium Carbonate	15	$111

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

Company	Paid to this provider	Part D cost of their drugs
Teva Pharmaceuticals USA, Inc.Austedo	$795	$72,73112 claims
Otsuka America Pharmaceutical, Inc.Rexulti	$813	$38,95916 claims
ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)Caplyta	$1,600	$17,01411 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 2,724 psychiatric/mental health providers in Texas.

Other psychiatric/mental health in Lewisville

Shelly BishardLewisville$18K
Tracy HicksLongview$684K
Natalie TellezHouston$602K
Karah BrashierRichardson$567K
Grant DavisRichardson$360K
Victor IlogEl Paso$167K
Lisa ShamblinGrapevine$163K
Monique GonzalezSan Antonio$126K
Marguerite AddisonWaco$118K
Komi Kokou-AbiRound Rock$88K

See the full list for Texas →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →